Jaguar Health, Inc. (JAGX)
NASDAQ·Healthcare·Biotechnology
$2.18
-8.02%
Mkt Cap $3.97M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$3.21
Range $3.21 – $3.21
Implied Upside
+47.2%
Consensus $3.21 vs current $2.18
NASDAQ·Healthcare·Biotechnology
$2.18
-8.02%
Mkt Cap $3.97M
No recent rating data.
Price Target (2 analysts)
$3.21
Range $3.21 – $3.21
+47.2%
Consensus $3.21 vs current $2.18